🟢 GH Research is trading 6.7% up in pre-market; catalyst remains uncertain

GH Research is trading 6.7% up now at $29.41, with no fresh company announcement clearly explaining the September 10, 2026 pre-market move.

• It rose from the September 9 close of $27.56.
• Recent coverage highlights H.C. Wainwright’s maintained Buy rating and $65 price target, citing FDA progress; the research is not clearly new and does not establish causation.
• Broader markets are nearly flat, leaving the catalyst uncertain.